← United States · Coverage record
US · SEC FORM 4
BIOMARIN PHARMACEUTICAL INC
BMRN · Nasdaq · CIK 0001048477 · Healthcare · Biotechnology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
14 Form 4 transaction lines observed in the same window
2 sales · 12 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 7 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2022-10-31 · Alles Mark J.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 11,522,835
- Previous report
- 10,075,655
- Avg daily volume
- 2,090,642
- Days to cover
- 5.5
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2022-10-31 | Alles Mark J | Purchase (P) | Common Stock | 3,625 | USD 86.75 | USD 314,469 | SEC filing ↗ |
| 2020-08-31 | PYOTT DAVID E I | Purchase (P) | Common Stock | 12,800 | USD 78.26 | USD 1,001,774 | SEC filing ↗ |
Form 4 evidence
49 transaction lines in the latest 365-day window; 650 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Friberg Gregory R | Tax withholding (F) | Common Stock | 4,086 | USD 60.00 | USD 245,160 | SEC filing ↗ |
| 2026-09-10 | Plenge Robert M | Award / grant (A) | Common Stock | 6,140 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-02 | Davis George Eric | Sale (S) | Common Stock | 17,557 | USD 66.28 | USD 1,163,678 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Friberg Gregory R | Tax withholding (F) | Common Stock | 4,086 | USD 60.00 | USD 245,160 | SEC filing ↗ |
| 2026-09-10 | Plenge Robert M | Award / grant (A) | Common Stock | 6,140 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-02 | Davis George Eric | Sale (S) | Common Stock | 17,557 | USD 66.28 | USD 1,163,678 | SEC filing ↗ |
| 2026-06-02 | Walbert Timothy P | Award / grant (A) | Common Stock | 7,490 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-02 | Ho Maykin | Award / grant (A) | Common Stock | 7,490 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-02 | HOMBACH ROBERT J. | Award / grant (A) | Common Stock | 7,490 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-02 | Enyedy Mark J | Award / grant (A) | Common Stock | 7,490 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-02 | Dere Willard H | Award / grant (A) | Common Stock | 7,490 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-02 | Countouriotis Athena | Award / grant (A) | Common Stock | 7,490 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-02 | CLARK IAN T | Award / grant (A) | Common Stock | 7,490 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-02 | Bodem Barbara W. | Award / grant (A) | Common Stock | 7,490 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-02 | ANDERSON ELIZABETH M | Award / grant (A) | Common Stock | 7,490 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-20 | Hubbard Cristin | Tax withholding (F) | Common Stock | 2,318 | USD 50.20 | USD 116,364 | SEC filing ↗ |
| 2026-05-07 | Friberg Gregory R | Sale (S) | Common Stock | 3,281 | USD 53.85 | USD 176,682 | SEC filing ↗ |
| 2026-03-18 | Davis George Eric | Tax withholding (F) | Common Stock | 1,273 | USD 56.05 | USD 71,352 | SEC filing ↗ |
| 2026-03-17 | Mueller Brian | Tax withholding (F) | Common Stock | 2,117 | USD 56.05 | USD 118,658 | SEC filing ↗ |
| 2026-03-17 | Hardy Alexander | Tax withholding (F) | Common Stock | 4,252 | USD 56.05 | USD 238,325 | SEC filing ↗ |
| 2026-03-17 | Guyer Charles Greg | Tax withholding (F) | Common Stock | 1,693 | USD 56.05 | USD 94,893 | SEC filing ↗ |
| 2026-03-17 | Hubbard Cristin | Tax withholding (F) | Common Stock | 1,245 | USD 56.05 | USD 69,782 | SEC filing ↗ |
| 2026-03-17 | Friberg Gregory R | Tax withholding (F) | Common Stock | 1,629 | USD 56.05 | USD 91,305 | SEC filing ↗ |
| 2026-03-16 | Hubbard Cristin | Award / grant (A) | Common Stock | 15,410 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-16 | Friberg Gregory R | Award / grant (A) | Common Stock | 19,150 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-16 | Mueller Brian | Award / grant (A) | Common Stock | 18,740 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-16 | Hardy Alexander | Award / grant (A) | Common Stock | 62,440 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-16 | Guyer Charles Greg | Award / grant (A) | Common Stock | 14,990 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-16 | Davis George Eric | Tax withholding (F) | Common Stock | 7,177 | USD 58.51 | USD 419,926 | SEC filing ↗ |
| 2026-03-16 | Davis George Eric | Award / grant (A) | Common Stock | 14,570 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-13 | Mueller Brian | Tax withholding (F) | Common Stock | 9,945 | USD 58.51 | USD 581,882 | SEC filing ↗ |
| 2026-03-13 | Hardy Alexander | Tax withholding (F) | Common Stock | 2,941 | USD 58.51 | USD 172,078 | SEC filing ↗ |
| 2026-03-13 | Guyer Charles Greg | Tax withholding (F) | Common Stock | 9,109 | USD 58.51 | USD 532,968 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | BMRN |
| CIK | 0001048477 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 650 transaction lines from 2020-01-07 to 2026-09-30 3 P purchase lines · 179 S sale lines · 468 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.